Hans Postlind
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
Papers in
- Pharmacology 15
- Pharmacogenetics and Drug Metabolism 15
-
- Vitamin D Research Studies 8
- Co-authors
- Lena Jendeberg (1 shared paper)Mona Sydow‐Báckman (1 shared paper)Rolf I. OHLSSON (1 shared paper)Patrik Blomquist (1 shared paper)Göran Bertilsson (1 shared paper)Kristian Svensson (1 shared paper)Anders L. Berkenstam (1 shared paper)Kjell Wikvall (6 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (4 papers)Biochemical Journal (4 papers)Proceedings of the National Academy of Sciences (2 papers)FEBS Letters (1 paper)Archives of Biochemistry and Biophysics (1 paper)
- Partner nations
- SwedenUnited States
In The Last Decade
Hans Postlind
18 papers receiving 1.4k citations
Hans Postlind's Hit Papers
Peers
Comparison fields: 5 of 88
- Pharmacology 745
- Oncology 324
- Health, Toxicology and Mutagenesis 149
- Toxicology 42
- Pathology and Forensic Medicine 132
Countries citing papers authored by Hans Postlind
This map shows the geographic impact of Hans Postlind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Postlind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Postlind more than expected).
Fields of papers citing papers by Hans Postlind
This network shows the impact of papers produced by Hans Postlind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Postlind. The network helps show where Hans Postlind may publish in the future.
Co-authors
The 22 scholars most cited alongside Hans Postlind, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Identification of a human nuclear receptor defines a new signaling pathway for CYP 3 A induction Hit paper breakdown → | 1998 | 756 |
| 2 | Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development. | 2007 | 252 |
| 3 | 1993 | 132 | |
| 4 | Tolterodine, a new muscarinic receptor antagonist, is metabolized by cytochromes P450 2D6 and 3A in human liver microsomes. | 1998 | 86 |
| 5 | 1994 | 62 | |
| 6 | 1997 | 36 | |
| 7 | 1992 | 26 | |
| 8 | Biotransformation of tolterodine, a new muscarinic receptor antagonist, in mice, rats, and dogs. | 1998 | 25 |
| 9 | 1991 | 22 | |
| 10 | 1995 | 21 | |
| 11 | 1990 | 18 | |
| 12 | 1990 | 15 | |
| 13 | 1989 | 14 | |
| 14 | 1988 | 12 | |
| 15 | 1996 | 9 | |
| 16 | 2000 | 9 | |
| 17 | 2005 | 9 | |
| 18 | 2004 | 8 |
About Hans Postlind
Hans Postlind is a scholar working on Pharmacology, Pathology and Forensic Medicine, Inorganic Chemistry, Health, Toxicology and Mutagenesis and Molecular Biology, having authored 18 papers that have together received 1.5k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (15 papers), Vitamin D Research Studies (8 papers), Metal-Catalyzed Oxygenation Mechanisms (4 papers), Steroid Chemistry and Biochemistry (4 papers), Toxic Organic Pollutants Impact (2 papers) and Cholesterol and Lipid Metabolism (1 paper). The work is most often cited by research in Pharmacology (745 citations), Oncology (324 citations), Health, Toxicology and Mutagenesis (149 citations), Toxicology (42 citations) and Pathology and Forensic Medicine (132 citations). Hans Postlind has collaborated with scholars based in Sweden and United States. Frequent co-authors include Lena Jendeberg, Mona Sydow‐Báckman, Rolf I. OHLSSON, Patrik Blomquist, Göran Bertilsson, Kristian Svensson, Anders L. Berkenstam, Kjell Wikvall, Robert H. Tukey and Paweł Baranczewski. Their work appears in journals such as Biochemical and Biophysical Research Communications, Biochemical Journal, Proceedings of the National Academy of Sciences, FEBS Letters and Archives of Biochemistry and Biophysics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.